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How much fluid is appropriate for the patient with acute
kidney injury (AKI) is still controversial. Different strategies
should be used for different patients according to their
clinical conditions. Generally speaking, in patients with
postrenal obstruction or intrinsic AKI such as glomerulone-
phritis, interstitial nephritis, or thromboembolism, there is
little disagreement that water should be restricted to avoid
fluid accumulation. On the other hand, in patients with
prerenal AKI and unstable hemodynamics, fluid therapy can
alleviate renal dysfunction.1
Insufficient fluid resuscitation impedes disease recovery,
but too much fluid may induce interstitial edema, which
results in end organ damage, poor wound healing, and
nosocomial infection.1 Contrary to more-liberal fluid ther-
apies in the past, conservative strategies are now being
advocated because recent studies found that more positive
fluid balance had poorer renal outcome and higher
mortality in critically ill patients with AKI.2,3* Corresponding author. Graduate Institute of Physiology, College
of Medicine, National Taiwan University, Number 1, Jen-Ai Road,
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The most common causes of AKI in critically ill patients are
sepsis, shock, and nephrotoxins such as radiocontrast.4,5
The rationale of fluid therapy is that restoration of hemo-
dynamic stability and renal blood flow will prevent acute
tubular necrosis. Adequate hydration is also suggested to
avoid AKI by nephrotoxins such as radiocontrast, amino-
glycosides, and nonsteroidal anti-inflammatory drugs.
Moreover, the surviving sepsis campaign has advocated
early goal-directed therapy with fluid therapy within the
initial 6 hours to achieve better tissue perfusion and less
tissue hypoxia in severe septic patients.
Adverse effect of fluid accumulation
Many patients become edematous if liberal fluid therapy
continues. Interstitial edema will impede capillary blood
flow and lymphatic drainage. Moreover, prolonged edema
will further impair diffusion of cellular oxygen and metab-
olite. Finally, cell dysfunction contributes to progressive
organ failure. Increased interstitial pressure and compro-
mised blood flow are more pronounced in encapsulated
organs such as liver and kidney.1 Fluid overload also
increases the risk of intra-abdominal hypertension, which is
strongly associated with development of AKI.1& Formosan Medical Association. All rights reserved.
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Many studies in the intensive care unit have shown that
liberal fluid therapy leads to worse prognosis. There are
various definitions of conservative and liberal fluid
therapy according to different studies. Van Biesen et al
found that septic patients with AKI had higher central
venous pressure (CVP), higher fluid load, and impaired
oxygenation than those without AKI.6 Payen et al2 found
that positive fluid balance was an independent factor
associated with increased mortality in septic patients with
AKI. Moreover, Bouchard et al3 found that AKI and
mortality was higher in patients with fluid overload (fluid
accumulation >10% of baseline body weight) and propor-
tional to the degree and duration of fluid overload. The
fluid overload group also had lower recovery rate of renal
function. In patients requiring renal replacement therapy
(RRT), survivors had lower fluid overload at dialysis initi-
ation and cessation.
The Fluid and Catheter Treatment Trial, by far the
largest multicenter, randomized, controlled trial studying
conservative (CVP of less than 4 mmHg and pulmonary
artery occlusion pressure of less than 8 mmHg) versus
liberal fluid therapy (CVP of 10e14 mmHg and pulmonary
artery occlusion pressure of 14e18 mmHg) in 1000 patients
with acute lung injury, found a significant decrease in the
requirement of RRT in the conservative fluid therapy
group.7 The study also showed that a positive fluid balance
after AKI was strongly associated with mortality.Optimal fluid status
The optimal fluid status should be individualized because
the response to fluid therapy depends on many factors such
as intravascular volume, myocardial compliance and
contractility, vascular resistance, and capillary perme-
ability.1 Even in the same patient, the optimal fluid status
should be reset when the condition changes. For example,
intensive fluid resuscitation is appropriate for hypovolemic
shock. In contrast, inotropes should be considered first, and
fluid should be restricted in patients with cardiogenic shock.
In septic patients, the International Surviving Sepsis
Campaign Guidelines Committee recommended fluid
therapy to achieve the target CVP. However, Turner et al8
demonstrated that sepsis induced myocardial injury which
could impair the heart contractility and reduce the toler-
ability of fluid accumulation. Therefore, in patients with
severe sepsis-induced myocardial suppression, timely
administration of vasopressors is important, and fluid
resuscitation should be more conservative.Guided fluid therapy
A precise, convenient, and cost-effective method is
necessary to guide fluid therapy. A systematic review
demonstrates a very poor relationship between CVP and
blood volume as well as the inability of CVP/DCVP to
predict the hemodynamic response to a fluid therapy.
Measuring the inferior vena cava diameter to monitor fluid
status is also operator-dependent and has many limitations.Pulmonary artery catheter-guided therapy does not
improve outcome and is invasive.
Transpulmonary thermodilution and pulse contour anal-
ysis by PiCCO catheter for fluid status monitoring is more
precise. Dynamic changes such as systolic pressure varia-
tion, pulse pressure variation, and stroke volume variation
derived from PiCCO catheter have also been shown to be
predictive of fluid responsiveness in mechanically venti-
lated patients, but they lose their value in patients with
spontaneous breathing activity and arrhythmias. Passive leg
raising induced changes in cardiac output and in arterial
pulse pressure can also predict fluid responsiveness.
However, more evidence is needed to prove better
outcome by these methods. On the other hand, a bio-
impedance device can monitor extracellular and intracel-
lular fluid but is only useful in the subsequent plateau phase
of acute severe illness, because it cannot monitor the other
hemodynamic parameters and has not been extensively
studied in critically ill patients.
Brain natriuretic peptide (BNP) is a potential marker for
fluid therapy. It can identify patients with fluid overload
and congestive heart failure. It has also been shown to
correlate with mortality and morbidity in critically ill
patients. BNP represents the tolerability of heart to intra-
vascular volume. It has been correlated with echocardio-
graphic and bioimpedance measures of fluid overload in
patients receiving RRT. Even without apparent fluid over-
load detected by the other methods, higher BNP means
intolerability of heart and fluid balance should be kept
negative if the hemodynamic status is stable. In a pilot
study, Ronco et al pointed out that elevated BNP level had
a higher risk of AKI.9 BNP seems to be a valuable noninva-
sive measure of fluid status in critical care, but the role of
BNP-guided fluid therapy should be assessed in a further
prospective study, and its optimal level is needed to be
validated because some diseases such as sepsis, heart
failure, and severe obstructive pulmonary disease have
a higher baseline BNP level.8
Fluid removal
Since critically ill patients with AKI have a higher fluid load,
negative fluid balance is beneficial once the hemodynamic
status becomes stable. Diuretics are usually considered the
first therapy to remove overloaded fluid, but their benefit is
controversial because diuretics induce neuroendocrine
reflex, which makes fluid removal more difficult. RRT
should be considered promptly to break this vicious cycle
when response to diuretics becomes inadequate.
Continuous renal replacement therapy (CRRT) is more
likely to correct fluid status than intermittent dialysis.3
Sustained low efficiency dialysis has comparable effec-
tiveness for fluid removal and is more convenient and cost-
effective than CRRT.10
Further perspective
Current evidence shows that conservative fluid therapy can
improve outcome in critically ill patients with AKI. Accurate
monitoring of fluid status plays a central role to guide the
fluid therapy and removal. However, a clinical device or
114 Y.-H. Chou et al.marker that is precise, convenient, and cost-effective to
monitor fluid status is still lacking. BNP seems to fulfill
these characteristics, but more randomized controlled
studies are needed to validate its performance.
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